RENX RenX Enterprises Corp.
Refuse Systems · Nasdaq · SEC CIK 1959023 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY221.6%
TTM net income YoY-115.8%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin32.3%
Operating margin-79.4%
Net margin-186.1%
FCF margin-124.5%
EBITDA margin-66.6%
Returns
ROE-990.3%
ROA-79.6%
ROIC (approx.)-35.5%
Asset turnover0.43x
Leverage & solvency
Liabilities / assets88.9%
Debt / equity5.93x
Current ratio0.11x
Interest coverage-1.13x
Cash quality & payout
Operating cash flow / net income0.48x
Accruals ratio-41.5%
Payout ratio—
Capex / revenue35.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $8.22M | $207,552 |
| Cost of revenue | $5.83M | $182,656 |
| Gross profit | $2.39M | $24,896 |
| SG&A expense | $4.18M | $1.53M |
| Operating income | -$12.45M | -$6.56M |
| Interest expense | $5.27M | $3.47M |
| Income tax | -$4.24M | -$1.92M |
| Net income | -$15.96M | -$8.91M |
| EBITDA | -$11.40M | -$6.56M |
| EPS (basic) | -83.99 | -195.69 |
| EPS (diluted) | -83.99 | -195.69 |
| Weighted avg. shares (diluted) | 233,211 | 45,524 |
| Balance sheet | ||
| Cash & equivalents | $54,066 | $227,766 |
| Receivables | $799,068 | — |
| Inventory | $1.08M | — |
| Current assets | $2.57M | $1.80M |
| PP&E, net | $11.80M | $6,045 |
| Goodwill | $6.24M | — |
| Intangibles | $11.26M | $1.04M |
| Total assets | $35.48M | $12.75M |
| Current liabilities | $21.61M | $10.40M |
| Short-term debt | $12.52M | $9.86M |
| Long-term debt | $8.24M | $1.50M |
| Total debt | $20.76M | $11.36M |
| Total liabilities | $31.08M | $11.90M |
| Shareholders' equity | $4.39M | $621,616 |
| Net debt | $20.71M | $11.13M |
| Shares outstanding | 938,559 | 60,522 |
| Cash flow statement | ||
| Operating cash flow | -$7.27M | -$2.56M |
| Capital expenditure | $3.62M | $3,488 |
| Free cash flow | -$10.89M | -$2.57M |
| Investing cash flow | -$3.53M | $239,664 |
| Financing cash flow | $10.21M | $3.27M |
| Depreciation & amortization | $1.05M | $1,012 |
| Stock-based compensation | $177,011 | $2.17M |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.